The proposed Extra Ordinary General Meeting of the Company stands deferred.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Relic Technologies has postponed its planned Extra Ordinary General Meeting, originally intended to seek shareholder approval for a change in the company's name and other related matters. The deferral is because the name change depends on the company first starting its new business activity in pharma and wellness products, which is a regulated sector requiring licenses and approvals from sectoral regulators. Since these approvals are still pending, the company cannot yet meet BSE's criteria for a name change. Once the necessary licenses are secured, revenue generation from the new activity begins, and BSE criteria are fulfilled, the company will seek shareholder approval for the name change at a future EGM. This follows an earlier announcement made on 13th December 2025.
This is a procedural update rather than a material business event. Shareholders should note that the planned name change and pivot into pharma/wellness are delayed pending regulatory clearances. No immediate financial impact is expected, but the timeline for the company's business transformation remains uncertain.